IP Library Granted Patent US 7,141,046
Granted Patent B2
US 7,141,046 · App. 10/017,068 · Granted Nov 28, 2006

Methods, systems, and kits for lung volume reduction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,046
App. No.
10/017,068
Granted
Nov 28, 2006
Kind
B2
Abstract

Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.

Claims (8)

1. A method for lung volume reduction, said method comprising:

isolating a lung tissue segment;

insufflating the isolated segment with an oxygen-rich gas to cause the segment to collapse by absorption atelectasis; and

sealing an air passage which opens to the lung segment to inhibit reinflation of the segment.

2. The method of claim 1 , wherein sealing comprises deploying a plug in the air passage.

3. The method of claim 2 , wherein deploying comprises advancing the plug through a catheter to the air passage.

4. A method as in claim 1 , wherein the gas is at least 50% oxygen by volume.

5. A method as in claim 4 , wherein the gas is at least 75% oxygen by volume.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2010
From: PERKINS, RODNEY C.; SOLTESZ, PETER P.; KOTMEL, ROBERT
To: PULMONX
Reel/Frame 023882/0115 →